Progressive supranuclear palsy is usually not hereditary. Nearly all cases appear in people with no relative who had it.1MedlinePlus Genetics. Progressive supranuclear palsy A handful of families do carry a rare inherited form, so “almost never” is more accurate than “never.”2Norman Fixel Institute for Neurological Diseases. Progressive Supranuclear Palsy (PSP) Information Page Genes still play a quieter role, shaping how likely someone is to develop PSP without deciding it.
What the Family Odds Actually Look Like
Most PSP arises in someone with no family history of it.3MedlinePlus Genetics. Progressive supranuclear palsy Among 375 people whose PSP was confirmed after death, only about 3% had a relative with PSP.4Journal of Movement Disorders. Genetics of Progressive Supranuclear Palsy The picture widens if you count other illnesses: 15% had a relative with PSP, parkinsonism, or dementia.5Journal of Movement Disorders. Genetics of Progressive Supranuclear Palsy
Relatives of people with PSP do seem to have slightly more movement disorders than other families. In one comparison, 33% of people with PSP had a parent, sibling, or child with dementia or parkinsonism, versus 25% of people without PSP.6PubMed. Familial aggregation of parkinsonism in progressive supranuclear palsy Parkinson-like illness specifically was noticeably more common among their close relatives.7PubMed. Familial aggregation of parkinsonism in progressive supranuclear palsy That suggests some shared inherited tendency, even when PSP itself doesn’t repeat.8PubMed. Familial aggregation of parkinsonism in progressive supranuclear palsy
Your own family tree is more useful than any average. List which relatives had PSP, Parkinson’s, or dementia, and at what age. One grandparent with Parkinson’s in late life is common and not a red flag. Several relatives across generations with early movement or memory problems is a different picture. Bring the list to the neurologist, since it shapes whether testing is worth discussing.
A relative’s diagnosis changes your odds only a little. PSP is rare to begin with, so even a modest increase in relative terms leaves the absolute chance low for a typical sibling or child.
A family history of other conditions is also not the same as a PSP family history. PSP, Parkinson’s disease, and the common dementias are different conditions, though early symptoms overlap and families often mix up the names. A relative described as having Parkinson’s or dementia may never have been examined for PSP, so the family’s account can be unreliable.
These percentages describe groups of patients, so they can’t give any one person a precise risk. Most come from people studied at specialist centers, whose family histories may not match the average family.
The Rare Inherited Form Caused by MAPT Mutations
MAPT is the gene that carries the instructions for making tau protein.9PubMed Central. A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy Changes in it are the most common cause of PSP that runs in families.10Neurology Perspectives. MAPT gene mutation in familiar progressive supranuclear palsy, a case report At least 15 different MAPT mutations have been found in people with a PSP-like illness,11Neurology Perspectives. MAPT gene mutation in familiar progressive supranuclear palsy, a case report and over 100 families worldwide have been identified with tau gene variants.12PubMed Central. A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy Some of these mutations push cells to make more of the type of tau that clumps in PSP.13Neurology Perspectives. MAPT gene mutation in familiar progressive supranuclear palsy, a case report Tau normally helps hold the internal scaffolding of nerve cells steady. In PSP, tau clumps build up in deep brain areas that control movement and eye motion.14PubMed. Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies Even so, families carrying them are rare compared with the large number of people who have PSP.
Inherited MAPT forms are autosomal dominant: one copy from one parent is enough.15PubMed Central. A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy Each child of a carrier has a 1 in 2 chance of inheriting the mutation. That chance is independent for each child, so one sibling can inherit it while another does not. A child who doesn’t inherit it cannot pass it on to their own children. Inheriting a mutation usually means a high chance of developing some illness, but the age of onset and the exact condition can differ even within one family.
In practice, a dominant pattern means affected people tend to appear in every generation rather than skipping, and men and women are affected equally. Symptoms often begin earlier than in typical PSP.
The same mutations often cause frontotemporal dementia with parkinsonism in other family members.16PubMed. Tau alternative splicing in familial and sporadic tauopathies Inherited MAPT illness can show up as changes in behavior or language, or as parkinsonism, rather than the classic PSP picture of falls and eye movement trouble. Different members of one family may receive different diagnoses even though a single mutation underlies all of them. Neurologists ask detailed family questions at diagnosis because inherited forms can look very similar to typical PSP.
Common Gene Variants That Raise Risk Slightly
People inherit either an H1 or H2 version of the tau gene region from each parent. The H1 version is linked with higher PSP risk and H2 with lower risk.17PubMed Central. MAPT Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes In one group, 89% of tau gene copies in people with PSP were H1, versus about 75% in healthy people.18PubMed Central. MAPT Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes Because the common H1 version is so common in healthy people too, carrying it tells you little on its own. One specific H1 subtype is a well-established risk version.19PubMed Central. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology
Several other genes add small effects. The largest genetic study of PSP found six gene regions linked to risk, including MAPT, MOBP, STX6, RUNX2, SLCO1A2, and C4A.20PubMed Central. Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes The tau gene region has by far the strongest effect of these,21PubMed Central. Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases while each of the others shifts risk only modestly.
A risk version differs from a disease-causing mutation. A MAPT mutation can cause illness almost directly, while a risk version like H1 only slightly raises the odds. PSP is rare, so even raised odds remain low for most people. Siblings share about half their DNA, so they often carry the same common versions. That shared background can add up to a small family tendency without any single mutation, and it partly explains the slightly higher family rates described earlier.
Most people carry at least one H1 copy and never develop PSP. Learning you carry H1 should not cause alarm, and it doesn’t change what you should do.
Findings also differ across ancestry. Most genetic research was done in people of European descent, and results may not apply equally to every family background.
Should You Get Genetic Testing
Doctors diagnose PSP from symptoms and examination, not a gene test.22PubMed Central. Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria Finding a rare mutation can instead point to a lookalike condition rather than true PSP.23PubMed Central. Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria Having two H2 copies makes PSP unlikely but doesn’t rule it out.24PubMed Central. Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria Routine testing of relatives without a family pattern rarely changes anything.
Testing makes more sense when the pattern is strong. Ask about it if several relatives had early PSP, frontotemporal dementia, or Parkinson-like illness. A genetic counselor can explain results, and what they mean for children, before you test. That matters because a positive result for a dominant mutation affects siblings and children too.
The affected person is usually tested first. If they carry an identifiable mutation, relatives can be tested for that exact change, which is more specific than a broad search. If they have no mutation, testing healthy relatives will likely reveal little.
Testing a relative who is well is a different decision. It can reveal a high chance of future illness that cannot yet be prevented, which is a heavy thing to learn. Some people prefer not to know, and that is a reasonable choice a counselor will respect.
Results have limits. A negative test in someone without a known family mutation doesn’t guarantee they are free of risk, because many causes are not yet known. A positive result tells you about the chance of illness but usually not when it will begin or how it will appear. Some results are uncertain, such as a variant whose meaning isn’t yet understood.
Consumer DNA kits don’t reliably screen for rare MAPT mutations, and a risk-version result is not a diagnosis. Meaningful answers need clinical testing ordered through a doctor.
Other Factors Beyond Genes
On the Caribbean island of Guadeloupe, a PSP-like illness was linked to eating soursop fruit and herbal teas.25PubMed. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? These plants contain natural toxins that can damage nerve cells.26PubMed. Atypical parkinsonism on Guadeloupe, comparison with the parkinsonism-dementia complex of Guam, and environmental toxic hypotheses Industrial pollutants and diet toxins are suspected in some regional differences worldwide.27PubMed Central. Progressive Supranuclear Palsy-A Global Review PSP likely results from genes and surroundings acting together.
The Guadeloupe findings concern a specific local diet and don’t mean ordinary fruit or teas elsewhere cause PSP. Cluster studies explain only a small part of the overall disease.
Older age is the clearest shared factor. PSP usually begins after about age 60. Most older people never develop it, though, so age can’t predict who will. Most cases have no identifiable cause at all.
For worried relatives, sharing a household or diet with a patient is not known to cause PSP. Families outside rare clusters have no specific foods to avoid. No proven way to prevent PSP exists yet, though healthy habits that support brain health remain reasonable. Relatives should not blame themselves or the patient’s past lifestyle.